GlassScriptPhysician profile
Claudia Charry
NPI 1992335038
$1,715.66
in general payments reported to CMS, 2019-2025
14 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.41 · 2022: $275 · 2023: $986 · 2024: $237 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.31 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $467.29 | 2021-2023 | Cardiomems |
| United Therapeutics Corporation | $378.31 | 2023-2025 | Orenitram, Remodulin, Tyvaso |
| Novartis Pharmaceuticals Corporation | $319.16 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $166.28 | 2023-2025 | Uptravi, Opsumit |
| Philips North America LLC | $109.21 | 2022-2024 | (Bq9) Coronary Ivus |
| Glaxosmithkline, LLC. | $66.08 | 2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $42.55 | 2024 | Libtayo |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $39.26 | 2025 | |
| Edwards Lifesciences Corporation | $34.94 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $24.70 | 2024 | Signia |
| Lilly USA, LLC | $18.50 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $16.83 | 2025 | Lumryz |
| Merck Sharp & Dohme LLC | $16.48 | 2024 | Keytruda |
| Solventum Corporation | $16.07 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Charry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.